Apimeds Pharmaceuticals US, Inc. Liquidation Value
APUS
Other
Cash & Equivalents
$6.99M
As of 2025-09-30
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $6.99M
Total Obligations: -$1.09M
$5.90M
Per share: $0.47
Period: 2025-09-30
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $6.99M
AR: $0
Total Obligations: -$1.09M
$5.90M
Per share: $0.47
Period: 2025-09-30
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $6.99M
AR: $0
Inventory: $0
Total Obligations: -$1.09M
$5.90M
Per share: $0.47
Period: 2025-09-30
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $5.90M | $0.47 |
| Liquid Liquidation Value | $5.90M | $0.47 |
| Operating Liquidation Value | $5.90M | $0.47 |
Key Components (as of 2025-09-30)
| Cash & Equivalents | $6.99M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $1.09M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 12.6M |
Explore all 77 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $6.99M | N/A | N/A | N/A | $1.09M | N/A | N/A | N/A |
| 2025-06-30 | $8.74M | N/A | N/A | N/A | $809,002 | N/A | N/A | N/A |
| 2025-03-31 | $250,342 | N/A | N/A | N/A | $1.77M | N/A | N/A | N/A |
▼ Community Notes